Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy
NCT ID: NCT05536297
Last Updated: 2025-07-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
278 participants
INTERVENTIONAL
2022-09-26
2025-04-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
NCT03525613
A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular Degeneration
NCT06970665
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
NCT03295877
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
NCT06779773
A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7303359 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
NCT04615325
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
avacincaptad pegol
Participants will receive avacincaptad pegol 2 mg monthly from Month 1 to Month 17.
avacincaptad pegol
Intravitreal Injection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
avacincaptad pegol
Intravitreal Injection
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient must provide new written informed consent for this OLE trial prior to participation.
* Patient must have the ability to return for all trial visits for the duration of the 18-month trial.
Exclusion Criteria
* Patient who had the study drug permanently withdrawn for an AE during ISEE2008 are not eligible.
* Patient did not enroll into this OLE trial within the 90 day enrollment period.
* Patient who is pregnant or nursing
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Astellas Pharma Global Development, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Medical Director
Role: STUDY_DIRECTOR
Astellas Pharma Global Development, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Retinal Diagnostic Center
Campbell, California, United States
Eye Medical Center of Fresno
Fresno, California, United States
Retina Consultants of Orange County
Fullerton, California, United States
Jacobs Retina Center at The Shiley Eye Institute USCD
La Jolla, California, United States
Jules Stein Eye Institute David Geffen School of Medicine
Los Angeles, California, United States
Doheny Eye Center, UCLA
Pasadena, California, United States
Retina Consultants of Southern California
Redlands, California, United States
Orange County Retinal Med Group
Santa Ana, California, United States
University of Colorado
Aurora, Colorado, United States
Retina Consultants of Southern CO
Colorado Springs, Colorado, United States
Colorado Retina Associates, PC
Lakewood, Colorado, United States
Rand Eye Institute
Deerfield Beach, Florida, United States
Retina Group of Florida
Fort Lauderdale, Florida, United States
Florida Eye Associates
Melbourne, Florida, United States
Retina Care Specialists
Palm Beach Gardens, Florida, United States
Retina Associates of Sarasota
Sarasota, Florida, United States
Retina Vitreous Associates of Florida
St. Petersburg, Florida, United States
East Florida Eye Institute
Stuart, Florida, United States
Southern Vitreoretinal Associates
Tallahassee, Florida, United States
Center for Retina & Macula Disease
Winter Haven, Florida, United States
Southeast Retina Center P.C.
Augusta, Georgia, United States
Retina Consultants of Hawaii, Inc.
‘Aiea, Hawaii, United States
Illinois Eye Center
Peoria, Illinois, United States
Vitreo Retinal Consultants & Surgeons
Wichita, Kansas, United States
Ochsner Clinic Foundation
New Orleans, Louisiana, United States
The Retina Group of Washington
Chevy Chase, Maryland, United States
Cumberland Valley Retina Consultants
Hagerstown, Maryland, United States
Ophthalmic Consultants of Boston
Boston, Massachusetts, United States
Retina Research Institute at New England Retina
Springfield, Massachusetts, United States
Vitreoretinal Associates PC
Worcester, Massachusetts, United States
Sierra Eye Associates
Reno, Nevada, United States
Retina Vitreous Surgeons of Central New York
Liverpool, New York, United States
Ophthalmic Consultants of Long Island
Oceanside, New York, United States
Retina Associates of Western NY
Rochester, New York, United States
Western Carolina Retinal Associates
Asheville, North Carolina, United States
Retina & Vitreous Center of Southern Oregon, PC
Ashland, Oregon, United States
Retina Northwest PC
Portland, Oregon, United States
Eye Health Northwest
Portland, Oregon, United States
Mid Atlantic Retina - Wills Eye Institute
Philadelphia, Pennsylvania, United States
Associates in Ophthalmology
West Mifflin, Pennsylvania, United States
Retina Research of Beaufort
Beaufort, South Carolina, United States
Palmetto Retina Center
West Columbia, South Carolina, United States
Black Hills Regional Eye Institute
Rapid City, South Dakota, United States
Southeastern Retina Associates, PC
Knoxville, Tennessee, United States
Retina Research Institute of Texas, LLC
Abilene, Texas, United States
Southwest Retina Specialists
Amarillo, Texas, United States
Austin Retina Associates
Austin, Texas, United States
Retina Foundation of the Southwest
Dallas, Texas, United States
Retina Center of Texas
Southlake, Texas, United States
Retina Consultants of Houston
The Woodlands, Texas, United States
Strategic Clinical Research Group, LLC
Willow Park, Texas, United States
Retina Associates of Utah PC
Salt Lake City, Utah, United States
Pacific Northwest Retina
Bellevue, Washington, United States
Oftalmólogos Especialistas
Rosario, Sante Fe, Argentina
Centro Oftalmológico Dr. Charles
Buenos Aires, , Argentina
Instituto Oftalmologico de Buenos Aires
Buenos Aires, , Argentina
Oftar Mendoza
Mendoza, , Argentina
Microcirugia Ocular
Santa Fe, , Argentina
Centre for Eye Research Australia
East Melbourne, , Australia
Sydney Retina Clinic
Sydney, , Australia
Medizinische Universitat Graz
Styria, , Austria
Medizinische Universitat Innsbruck
Tyrol, , Austria
Medical University of Vienna, Department of Ophthalmology and Optometry
Vienna, , Austria
Centre H. U. Brugmann
Brussels, , Belgium
Centro de Ensino e Pesquisa do Instituto de Visao
Belo Horizonte, , Brazil
Universidade Federal de Sao Paulo
São Paulo, , Brazil
IPEPO - Instituto da Visao
São Paulo, , Brazil
Calgary Retina Consultants
Calgary, Alberta, Canada
St. Joseph's Health Care London
London, Ontario, Canada
Retina Centre of Ottawa
Ottawa, Ontario, Canada
Fundacion Oftalmologica Nacional
Bogotá, , Colombia
Clinica de Oftalmologia Sandiego
Medellín, , Colombia
Clinical Hospital Osiiek, Ophthalmology Clinic
Osijek, , Croatia
Lékárna nad Knížecí Kováků
Smíchov, , Czechia
University Hospital of Bordeaux
Bordeaux, , France
Hopital Intercommunal de Creteil
Créteil, , France
Pole Vision Val D'Ouest
Écully, , France
Centre Ophtalmologique Rabelais
Lyon, , France
Hopital de la Croix-Rousse
Lyon, , France
Centre Paradis-Monticelli
Marseille, , France
Centre D'exploration Ophtalmologique De L'odéon
Paris, , France
Centre d'Imagerie et Laser
Paris, , France
Rothschild Foundation
Paris, , France
Hopital Lariboisiere, Service Pharmacie
Paris, , France
Centre Ophtalmologique Saint Exupéry
Saint-Cyr-sur-Loire, , France
Universitätsklinikum Hamburg Eppendorf
Hamburg, , Germany
Universitätsklinik für Augenheilkunde, Medizinische Hochschule Hannover
Hanover, , Germany
Augenklinik der Ludwig-Maximilian Universität München
München, , Germany
Eye Clinic Ludwig Maximilian
München, , Germany
Augenzentrum am St. Franziskus-Hospital
Münster, , Germany
Dept. of Ophthalmology Semmelweis University Budapest
Budapest, , Hungary
Bajcsy Zsilinszky Korhaz Szemeszet
Budapest, , Hungary
Budapest Retina Associates
Budapest, , Hungary
Barzilai Medical Center
Ashkelon, , Israel
Carmel Medical Center
Haifa, , Israel
Kaplan Medical Center
Rehovot, , Israel
Shamir Medical Center
Tzrifin, , Israel
AOU Policlinico S. Orsola-Malpighi
Bologna, , Italy
Clinica Oftalmologica Ospedale C. S.S. Annunziata
Chieti, , Italy
Ospedaliero Universitaria di Ferrara
Ferrara, , Italy
Ospedale Maggiore Policlinico
Milan, , Italy
Ospedale San Raffaele
Milan, , Italy
Azienda Ospedaliera Fatebenefratelli
Milan, , Italy
Azienda Ospedaliera U. della Campania "Vanvitelli"
Napoli, , Italy
Policlinico Tor Vergata
Roma, , Italy
Azienda Ospedaliero-U.Ospedali Riuniti Umberto I
Torrette Di Ancona, , Italy
P. Stradins Clinical university hospital
Riga, , Latvia
Hospital Universitario Puerta de Hierro-Majadahonda
Majadahonda, Madrid, Spain
Clinicade Oftalmologia Barraquer
Barcelona, , Spain
Institut Catala de la Retina
Barcelona, , Spain
Instituto Clinico Quirurgico de Oftalmologia
Bilbao, , Spain
Hospital La Arruzafa
Córdoba, , Spain
Valles Ophthalmology Research (VOR) in Hospital General de Catalunya Pedro
Sant Cugat del Vallès, , Spain
Instituto Oftalmológico Gómez-Ulla
Santiago de Compostela, , Spain
IMED Servicio Oftalmología
Valencia, , Spain
Rio Hortega University Hospital
Valladolid, , Spain
Hospital Clínico Universitario "Lozano Blesa"
Zaragoza, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-002860-59
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
2024-515185-13-00
Identifier Type: REGISTRY
Identifier Source: secondary_id
ISEE2009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.